Jennifer Bowe Email & Phone Number

Waynesville, Oh, Us

Cincinnati, Ohio, United States

*Increased volume and market share for Sanofi's injectable Diabetes portfolio: Soliqua 100/33, Toujeo & Toujeo Max during a difficult COVID impacted time.*Recognized for exceeding goals, organized and impactful Omnichannel approach to engage customers, and strong customer relationships*WISE Leadership member since 2021 (WISE- Women Inspiring Sanofi Excellence)*Panel member for Virtual and Omnichannel engagement

Dayton Oh

Launched Cardiovascular Outcomes data for Jardiance. Sold Tradjenta and Glyxambi on both the East and West sides of Dayton.

Dayton, Ohio Area

Launched Farxiga and Xigduo XR. Sold Onglyza and Kombiglyze XR. Responsible for territory, budget, and resource management as well as building professional relationships in order to grow branded oral anti-diabetic drugs in a generic threatened market. • April results: Farxiga 26/98 MS 26.35% (#2 in district) Onglyza 24/98 MS 10.12% (#1 in district) • Earned Portfolio Kicker Award for having all products above 100% for Q4• Won Xigduo XR Sprint to the Finish contest $1400 cash prize• Achieved fast start to Xigduo XR launch- 2 NRx in 1st week. Entire district had 5 NRx.• Maintaining Onglyza and Kombiglyze XR business during FX/XXR launch in a generic heavy market. • Team leader for all data analysis, organization, and progress tracking• Recognized by my Manager perfect admin, having a “willing to try attitude”, teamwork and leadership, and focus on growth in 2015.

Dayton Oh

Sold Crestor to Primary Care Physicians (70%) and Cardiologists (30%) in the Dayton market. Responsible for territory, budget, and resource management as well as building professional relationships in order to grow Crestor in a generic threatened market. • Grew Crestor NRx market share by 5.89% as of June. Led our district in June with a 7.1% NRx growth.• Regional ranking moved up from 26/113 in Q1 to 19/113 in Q2. (Top 23% to top 16%) • Nationally ranked 92/477 in Q1. (Top 19%) • Recognized by my Manager for the Extra Mile Reward by demonstrating behaviors aligned with sales success.

Sold Onglyza, Kombiglyze XR, Plavix, and Avapro to Primary Care Physicians in the Cincinnati market. Successfully launched two new diabetes products into a generic marketplace. Responsible for territory management, budget/resource management, sample accountability, building and maintaining professional relationships with key physicians in order to grow market share. • Ended Contract with my highest week to date for Onglyza Franchise of 43 TRx. Current 4 weeks up 30% over previous 4 weeks. • Launched new Diabetes product Kombiglyze XR. Successfully grew sales this year from 0 to 373 through 9/30/2011. • Launched new Diabetes product Onglyza in August 2009. Grew rx this year from 0-1,855 through 9/30/2011. • In first year grew Onglyza/Kombiglyze XR trialists from 0 to 79% with 36% of those being consistent repeaters. 50% of those repeaters are tier 1 physicians. • Recognized by Regional Manager as a top product presenter for our region at Insight training meeting.• 2nd place in Onglyza launch contest based on Market Share and new trialists.

Generated sales leads to sell TV advertising spots as well as promotional production for WSTR my64 Cincinnati. Responsible for contract and cost per point negotiations with buyers. Developed strong customer relationships to benefit both WSTR and clients. Recognized by management as a consistent closer and for my ability to discover viable prospects.Closed first account within one month of employment for $16,000.00.

Cincinnati East

Sold the cardiovascular flagship product for Novartis as the lead sales force: Diovan/Diovan Hct: 2 Billion/year. Also sold Lotrel, Exforge, Tekturna, and Starlix. Responsible for efficient territory management, sample/budget accountability, building and maintaining professional relationships with key physicians for market share growth. Successfully launched Exforge and Tekturna into a highly cost conscience generic market. • Moved ranking from 59/65 to 12/65 within 6 months of taking the lead for top 2 products and consistently remained in top third of region. Finished at 5/65 in Region. Finished at 1/12 in District. • Won Azor Blunting contest in January 2008 by growing market share for our launch product Exforge, while blunting any share growth of new competing products. • Reversed negative sales trend for Diovan Hct by leading POD to ensure solid growth of a well-established product during the launch of two new cardiovascular products: Exforge/Tekturna. • Managed a 33K budget, strategically planning multiple educational programs ensuring the highest return on investment through specific targeting and business analysis. • Worked to develop Key Opinion Leaders to serve as advocates for our cardiovascular portfolio. These KOLs grew to over a 50% market share for Novartis products and remained loyal prescribers. • Recognized for creativity and persistence in finding new sales opportunities for products that have already been on the market for 10+ years.

B.A, Psychology

Graduated with Honors

Work, Biology, Psychology, And Communication

Activities and Societies: Track, Diving, and Alpha Chi Omega

Education record

Undergraduate work in Physiopsychology

B.A, Psychology

Education record

Undergraduate work in Physiopsychology

Undergraduate, Biology, Psychology, And Communication

Bachelor'S Degree, Psychology And Communications